|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28.02.26 - 02:06
|
Stocks Slide as Credit Stress, War and AI Fears Weigh | The Close 2/27/2026 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Robinhood Markets' Stephanie Guild, Generate:Biomedicines' Mike Nally, S&P Global's Simon Gallagher, Inflation Insights' Omair Sharif, Lightshed Partners' Rich Greenfield, Fidelity's Jurrien Timmer, Institute for Advance Study's Alondra Nelson, Hornets Sports and Entertainment's Shelly Cayette-Weston, Raising Cane's Aj Kumaran, and Carnegie Endowment for International Peace Senior Fellow Aaron David Miller. (Source: Bloomberg)...
|
|
|
|
|
28.02.26 - 01:12
|
President Trump′s Economy: Boom, Bust, or Business as Usual? (Bloomberg)
|
|
|
President Trump says inflation is plunging, incomes are rising, and the economy is “roaring.” Former Obama economic adviser Jason Furman offers a reality check. Growth has been steady and unemployment stable, but tariffs are adding costs, policy uncertainty remains high, and the AI boom may not yet justify massive investment. With the Supreme Court striking down key tariffs and refund battles looming, the bigger question is whether today's stability masks deeper long-term risks. (Source: Bloomberg)...
|
|
|
28.02.26 - 01:12
|
The Key to a Healthy Woman′s Heart (Bloomberg)
|
|
|
February is American Heart Month, known as a critical time for bringing increased attention to cardiovascular health and the prevention of heart disease, which is the leading cause of death in the US. Women are particularly vulnerable to cardiac health threats spanning biological, clinical and healthcare system factors that contribute to underdiagnosis, delayed treatment, and worse outcomes compared to men. Dr. Joy Gelbman, Associate Professor of Medicine at Weill Cornell Medicine as well as a board-certified cardiologist, is well-versed in the unique challenges facing women when it comes to their cardiac health. She breaks down specific sex-specific risk factors, differing disease presentation and pathophysiology, as well as the experience disparities in treatments and outcomes. Dr. Gelbman speaks with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily. (Source: Bloomberg)...
|
|
|
28.02.26 - 01:01
|
Former Netflix Executive on The WBD-PSKY Merger (Bloomberg)
|
|
|
Simon Gallagher, Managing Director at SPG Global, says Netflix's outlook remains strong even without Warner Bros. Discovery content. He speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)...
|
|
|
28.02.26 - 01:01
|
Anthropic-Pentagon Hiccup ′Opens Door for OpenAI′: Nelson (Bloomberg)
|
|
|
Alondra Nelson, Harold F. Linder Professor at the Institute for Advanced Study and a member of the UN advisory body on AI, says she doesn't believe Anthropic is going anywhere, noting that much can change in the next six months. She speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)...
|
|
|
28.02.26 - 01:01
|
Vir Bio CEO on Cancer Treatment Progress, Potential Deals (Bloomberg)
|
|
|
Vir Biotechnology Vir is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company on Monday announced new data from the ongoing Phase 1 clinical trial of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeting, PRO-XTEN dual-masked T-cell engager (TCE) being evaluated in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) who have progressed after multiple lines of therapy. These data suggest that VIR-5500 monotherapy is well tolerated and exhibits promising anti-tumor activity. Vir CEO Marianne De Backer discusses the progress being made with the firm's leading treatments, the runup in its share price thus far in 2026, and why partnerships are key to advancing Vir's impact. Dr. De Backer speaks with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily. (Source: Bloomberg)...
|
|
|
|
|
28.02.26 - 01:01
|
Charlotte Hornets Aim to Generate Buzz Under New Owners (Bloomberg)
|
|
|
Shelly Cayette-Weston, President of Business Operations for the Charlotte Hornets, discusses the team's strategic initiatives to enhance the fan experience and drive economic development in Charlotte. She speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)...
|
|
|
|